cas: 85815-37-8 Rilmazafone Hydrochloride
cas: 85815-37-8 Rilmazafone Hydrochloride
CBNumber: CB02469946
Chemical Name: Rilmazafone Hydrochloride
Molecular Formula: C21H21Cl3N6O3
Formula Weight: 511.79
CAS No.: 85815-37-8
Rilmazafone Rhythmy, previously known as 450191-S is a water-soluble prodrug developed in Japan. Once metabolized, rilmazafone is converted into several benzodiazepine metabolites that have sedative and hypnotic effects These metabolites induce impairment of motor function and have hypnotic properties.
Rilmazafone is not a benzodiazepine, since there is no benzene ring fused with a diazepine ring in the compound; in fact, the parent drug has no diazepine ring. It is therefore not classified as a benzodiazepene in several countries, including the United States, where it is not designated a controlled substance. Rilmazafone has no effects on benzodiazepine receptors itself, nor does it produce any psychoactive effects prior to metabolism. However, once inside the body it is metabolized by aminopeptidase enzymes in the small intestine to form the principal active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo [1,5-a]benzodiazepine-2-carboxamide.As can be seen in the molecular diagram below, the principal metabolite contains a benzodiazepine ring structure (i.e., a benzene ring fused with a diazepine ring), unlike the parent compound (rilmazafone), which has no diazepine ring
Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effects on benzodiazepine receptors itself, but once inside the body is metabolised by aminopeptidase enzymes in the small intestine to form the active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo benzodiazepine-2-carboxamide. Preclinical studies have shown its excellent effects inducing and maintaining sleep with little effect on the skeletal muscle. Earlier the clinical dose for this drug as a premedicant was found to be 2-4mg. Zolpidem Triazolam Rilmazafone Elderly Residual effects Randomized study,
Rilmazafone is considered to be a benzodiazepine pro-drug, and in Japan, is used for the short-term treatment of insomnia. Benzodiazepines are scheduled as Prescription Medicines in Schedule 1 of the Medicines Regulations 1984. However, rilmazafone is itself not a benzodiazepine.
-
41:46
Standpoint with Gabe Groisman
18 hours agoEp. 27. From GameStop to the NBA. Gabe Plotkin
76.4K6 -
55:04
Matt Kohrs
15 hours agoThe Volatile Week Ahead || The MK Show
82.2K24 -
26:18
Stephen Gardner
15 hours agoTop Republican UNLOADS on Democrats and Biden's MENTAL HEALTH!!
89.8K116 -
44:30
Michael Franzese
2 days agoCancel Culture Backlash of My UK Tour | Michael Franzese
148K53 -
35:12
Island Hopper TV
1 day ago $13.34 earnedFull Costa Rica Travel Guide 2024
97.9K33 -
4:43
ParisDemers
1 day agoThis Diet Hack Changed My Life! (How To Get Ripped FAST!)
102K32 -
46:57
Crime Circus
1 day agoApple River ST*BBING!! Stand Your Ground Interrogation of Man in Wisconsin
102K46 -
9:39
Tactical Advisor
1 day agoHow To Improve Your Shooting For FREE! Mantis Blackbeard X
109K16 -
1:00:59
Squaring The Circle w/ Randall Carlson
1 day ago#007 The Real Climate Crisis Noone Is Talking About and Mount Tambora Pt 2
109K35 -
13:52
America Uncovered
1 day ago $24.89 earnedEveryone is WRONG About Trump's Guilty Verdict
84.9K129